Literature DB >> 29286988

Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study.

Shannon K Laughlin-Tommaso1,2, Zaraq Khan3, Amy L Weaver4, Carin Y Smith4, Walter A Rocca5,6,7, Elizabeth A Stewart2,3,7.   

Abstract

OBJECTIVE: The aim of the study was to determine the long-term risk of cardiovascular disease and metabolic conditions in women undergoing hysterectomy with bilateral ovarian conservation compared with age-matched referent women.
METHODS: Using the Rochester Epidemiology Project records-linkage system, we identified 2,094 women who underwent hysterectomy with ovarian conservation for benign indications between 1980 and 2002 in Olmsted County, Minnesota. Each woman was age-matched (±1 y) to a referent woman residing in the same county who had not undergone prior hysterectomy or any oophorectomy. These two cohorts were followed historically to identify de novo cardiovascular or metabolic diagnoses. We estimated hazard ratios (HRs) and 95% CIs using Cox proportional hazards models adjusted for 20 preexisting chronic conditions and other potential confounders. We also calculated absolute risk increases and reductions from Kaplan-Meier estimates.
RESULTS: Over a median follow-up of 21.9 years, women who underwent hysterectomy experienced increased risks of de novo hyperlipidemia (HR 1.14; 95% CI, 1.05-1.25), hypertension (HR 1.13; 95% CI, 1.03-1.25), obesity (HR 1.18; 95% CI, 1.04-1.35), cardiac arrhythmias (HR 1.17; 95% CI, 1.05-1.32), and coronary artery disease (HR 1.33; 95% CI, 1.12-1.58). Women who underwent hysterectomy at age ≤35 years had a 4.6-fold increased risk of congestive heart failure and a 2.5-fold increased risk of coronary artery disease.
CONCLUSIONS: Even with ovarian conservation, hysterectomy is associated with an increased long-term risk of cardiovascular and metabolic conditions, especially in women who undergo hysterectomy at age ≤35 years. If these associations are causal, alternatives to hysterectomy should be considered to treat benign gynecologic conditions.

Entities:  

Year:  2018        PMID: 29286988      PMCID: PMC5898981          DOI: 10.1097/GME.0000000000001043

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  37 in total

1.  Risk of myocardial infarction after oophorectomy and hysterectomy.

Authors:  M Falkeborn; C Schairer; T Naessén; I Persson
Journal:  J Clin Epidemiol       Date:  2000-08       Impact factor: 6.437

2.  Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation.

Authors:  Shannon K Laughlin-Tommaso; Zaraq Khan; Amy L Weaver; Cathy D Schleck; Walter A Rocca; Elizabeth A Stewart
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

3.  Subclinical atherosclerosis in relation to hysterectomy status in black women.

Authors:  C M Zeigler-Johnson; J L Holmes; H C Lassila; K Sutton-Tyrrell; L H Kuller
Journal:  Stroke       Date:  1998-04       Impact factor: 7.914

4.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Joshua J Pankratz; Scott M Brue; Walter A Rocca
Journal:  Int J Epidemiol       Date:  2012-11-18       Impact factor: 7.196

5.  The association of hysterectomy and menopause: a prospective cohort study.

Authors:  Cynthia M Farquhar; Lynn Sadler; Sally A Harvey; Alistair W Stewart
Journal:  BJOG       Date:  2005-07       Impact factor: 6.531

6.  Trends in bilateral oophorectomy at the time of hysterectomy for benign disease.

Authors:  Akiva P Novetsky; Leslie R Boyd; John P Curtin
Journal:  Obstet Gynecol       Date:  2011-12       Impact factor: 7.661

7.  Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.

Authors:  Albert Asante; Maura K Whiteman; Aniket Kulkarni; Shanna Cox; Polly A Marchbanks; Denise J Jamieson
Journal:  Obstet Gynecol       Date:  2010-11       Impact factor: 7.661

8.  Nationwide trends in the performance of inpatient hysterectomy in the United States.

Authors:  Jason D Wright; Thomas J Herzog; Jennifer Tsui; Cande V Ananth; Sharyn N Lewin; Yu-Shiang Lu; Alfred I Neugut; Dawn L Hershman
Journal:  Obstet Gynecol       Date:  2013-08       Impact factor: 7.661

9.  Increased cardiovascular mortality after early bilateral oophorectomy.

Authors:  Cathleen M Rivera; Brandon R Grossardt; Deborah J Rhodes; Robert D Brown; Véronique L Roger; L Joseph Melton; Walter A Rocca
Journal:  Menopause       Date:  2009 Jan-Feb       Impact factor: 2.953

10.  Defining and measuring chronic conditions: imperatives for research, policy, program, and practice.

Authors:  Richard A Goodman; Samuel F Posner; Elbert S Huang; Anand K Parekh; Howard K Koh
Journal:  Prev Chronic Dis       Date:  2013-04-25       Impact factor: 2.830

View more
  22 in total

1.  Mental health conditions diagnosed before bilateral oophorectomy: a population-based case-control study.

Authors:  Liliana Gazzuola Rocca; Carin Y Smith; William V Bobo; Brandon R Grossardt; Elizabeth A Stewart; Shannon K Laughlin-Tommaso; Walter A Rocca
Journal:  Menopause       Date:  2019-12       Impact factor: 2.953

2.  Long-term risk of de novo mental health conditions after hysterectomy with ovarian conservation: a cohort study.

Authors:  Shannon K Laughlin-Tommaso; Anisha Satish; Zaraq Khan; Carin Y Smith; Walter A Rocca; Elizabeth A Stewart
Journal:  Menopause       Date:  2020-01       Impact factor: 2.953

3.  Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: A population-based case-control study.

Authors:  Walter A Rocca; Liliana Gazzuola Rocca; Carin Y Smith; Brandon R Grossardt; Stephanie S Faubion; Lynne T Shuster; Elizabeth A Stewart; Michelle M Mielke; Kejal Kantarci; Virginia M Miller
Journal:  Maturitas       Date:  2018-09-14       Impact factor: 4.342

4.  Does Saving Uterus Save Ovaries?

Authors:  Suvarna Khadilkar
Journal:  J Obstet Gynaecol India       Date:  2020-03-18

5.  FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery.

Authors:  Shannon Laughlin-Tommaso; Emily P Barnard; Ahmed M AbdElmagied; Lisa E Vaughan; Amy L Weaver; Gina K Hesley; David A Woodrum; Vanessa L Jacoby; Maureen P Kohi; Thomas M Price; Angel Nieves; Michael J Miller; Bijan J Borah; James P Moriarty; Krzysztof R Gorny; Phyllis C Leppert; Amanda L Severson; Maureen A Lemens; Elizabeth A Stewart
Journal:  Am J Obstet Gynecol       Date:  2018-10-26       Impact factor: 8.661

6.  Laparoscopically Confirmed Endometriosis and Risk of Incident Stroke: A Prospective Cohort Study.

Authors:  Leslie V Farland; William J Degnan; Melanie L Bell; Scott E Kasner; Ava L Liberman; Divya K Shah; Kathryn M Rexrode; Stacey A Missmer
Journal:  Stroke       Date:  2022-07-21       Impact factor: 10.170

7.  Uterine fibroids and risk of hypertension: Implication of inflammation and a possible role of the renin-angiotensin-aldosterone system.

Authors:  Decio Armanini; Chiara Sabbadin; Gabriella Donà; Luciana Bordin; Loris Marin; Alessandra Andrisani; Guido Ambrosini
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-22       Impact factor: 3.738

8.  Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.

Authors:  Ayman Al-Hendy; Andrea S Lukes; Alfred N Poindexter; Roberta Venturella; Claudio Villarroel; Hilary O D Critchley; Yulan Li; Laura McKain; Juan C Arjona Ferreira; Andria G M Langenberg; Rachel B Wagman; Elizabeth A Stewart
Journal:  N Engl J Med       Date:  2021-02-18       Impact factor: 91.245

9.  Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists.

Authors:  Angela H E M Maas; Giuseppe Rosano; Renata Cifkova; Alaide Chieffo; Dorenda van Dijken; Haitham Hamoda; Vijay Kunadian; Ellen Laan; Irene Lambrinoudaki; Kate Maclaran; Nick Panay; John C Stevenson; Mick van Trotsenburg; Peter Collins
Journal:  Eur Heart J       Date:  2021-03-07       Impact factor: 29.983

10.  Uterine Fibroids and the Risk of Cardiovascular Disease in the Coronary Artery Risk Development in Young Adult Women's Study.

Authors:  Shannon K Laughlin-Tommaso; Erika L Fuchs; Melissa F Wellons; Cora E Lewis; Ronit Calderon-Margalit; Elizabeth A Stewart; Pamela J Schreiner
Journal:  J Womens Health (Larchmt)       Date:  2018-11-09       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.